Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...

Neoadjuvant Opdivo with platinum-doublet chemo had a statistically significant and clinically meaningful improvement versus ...

The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...

Candel Therapeutics (CADL) announced final overall survival data from the completed randomized controlled phase 2 clinical trial of CAN-2409 ...

Merck (MRK) announced the FDA has accepted for priority review a new supplemental Biologics License Application seeking approval for keytruda – ...

Bristol Myers Squibb & Co (NYSE:BMY) announced the final analysis of overall survival (OS) from the Phase 3 CheckMate -816 ...